Application of Electrical Neurostimulation Transcutaneous in Patients With Primary Dysmenorrhea.
NCT ID: NCT02205970
Last Updated: 2017-10-23
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
124 participants
INTERVENTIONAL
2010-08-31
2014-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
TENS active
TENS (interactive): frequency (90 and 150 pps) and pulse duration (300 and 400μs)
TENS
In the active group there was only one application with interactive TENS (n = 42) with the final parameters of frequency between 90 and 150pps and pulse duration between 300 and 400μs and intensity level of tolerance, lasting 35 minutes.
TENS sham
Placebo lasting 35 minutes.
TENS (sham)
In the placebo group, there was a simulated single application, following the same procedures as the active TENS group, also for 35 minutes.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
TENS
In the active group there was only one application with interactive TENS (n = 42) with the final parameters of frequency between 90 and 150pps and pulse duration between 300 and 400μs and intensity level of tolerance, lasting 35 minutes.
TENS (sham)
In the placebo group, there was a simulated single application, following the same procedures as the active TENS group, also for 35 minutes.
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Moderate to severe pain
Exclusion Criteria
* Users of intrauterine device
* Cognitive impairment
* Failure to appear for treatment
* Pacemaker use
* Illicit drug use
* Epilepsy
* Skin problems
* Use of pain medication before the application of TENS
18 Years
36 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Universidade Federal de Sao Carlos
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Fabio Mendes Camilo
Methodological Proposal of Application of Electrical Neurostimulation Transcutaneous (Comparative Study between Proposed Method of Application Versus Traditional method in patients with Primary Dysmenorrhea).
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Fábio M. Camilo, teacher
Role: PRINCIPAL_INVESTIGATOR
Fundação de Educação e Cultura de Santa Fé do Sul
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
036/2010
Identifier Type: OTHER
Identifier Source: secondary_id
UFSaoCarlos0001/14
Identifier Type: -
Identifier Source: org_study_id